Clinical Trials Logo

Clinical Trial Summary

To assess the diagnostic value of NGS screnning in prelingually deafned children using a new designed chip, and to evaluate its interest in a the neonatal screening program for ddetecting congenitally deafned children.


Clinical Trial Description

The aim of the study is to evaluate the diagnostic value of a new panel of gene in NGS study in children presenting :

1. A congenitally deafness : it is a retrospective study in children aged 0 to 17 yrs with hearing thresholds over 40 dB in the best ear using adapted audiometric assessment,

2. A suspicion of deafness in babies aged 0 to 6 months having an abnormal response after otoacoustic emissions and automated ABR assessment.

The main outcomes studied will be the finding of a pathogenic mutation (or several mutations). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04350619
Study type Observational
Source Clinica Universidad de Navarra, Universidad de Navarra
Contact Manuel Jesús M Manrique Rodriguez, ENT
Phone 948255400
Email mmanrique@unav.es
Status Not yet recruiting
Phase
Start date April 30, 2020
Completion date April 2021

See also
  Status Clinical Trial Phase
Completed NCT00400413 - Neuroanatomy of Reading in Congenital Deafness. N/A
Recruiting NCT05402813 - Natural History in Children up to 10 Years With Moderate to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
Completed NCT03319524 - Clinical and Genetic Testing of Patients With Usher Syndrome
Completed NCT00106743 - Natural History and Genetic Studies of Usher Syndrome
Terminated NCT03866850 - Degenerative Consequences of Congenital Deafness
Not yet recruiting NCT06370351 - A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations Phase 1/Phase 2
Not yet recruiting NCT06365749 - Genetic Feature of Congenital Hearing Loss in Chinese Population